
Wockhardt has high hopes for novel antibiotic Zaynich
Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.
Newsletters and Deep Dive digital magazine
Wockhardt has completed a pre-filing meeting with the FDA and is preparing to submit its novel antibiotic Zaynich in the US and Europe.
A new auction for bankrupt genetic testing company 23andMe looks likely after former CEO Anne Wojcicki offered to outbid Regeneron.
Women in the UK taking weight-loss injections have been warned by the MHRA that they should make sure they are using effective contraception.
With new guidance, the EMA is seeking to ramp up the inclusion of pregnant and breastfeeding women in clinical trials.
Brain-computer interface firm Neuralink has completed a $650m financing that it says will help to "bring our technology to more people."
Editor's Picks
Newsletters and Deep Dive
digital magazine